Projected Earnings Date: 2025-08-05    (Delayed quote data   2025-05-08)
Last
 36.52
Change
 ⇓ -0.20   (-0.54%)
Volume
  9,240,913
Open
 37.11
High
 38.03
Low
 35.46
8EMA (Daily)
 49.84
40EMA (Daily)
 65.18
50EMA (Daily)
 69.57
STO (Daily)
 37.943
MACD Hist (Daily)
 -3.097
8EMA (Weekly)
 61.084
40EMA (Weekly)
 98.93
50EMA (Weekly)
 102.99
STO (Weekly)
 10.190
MACD Hist (Weekly)
 -9.225
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com